Latest Genshin Impact Redeem Code: 160 Primogems FREE

Latest Genshin Impact Redeem Code: 160 Primogems FREE – Latest Genshin Impact code release. Here’s the redeem code to get free primogem!

Previously, miHoYo had provided several Genshin Impact redeem codes for October which players could claim for free. With more and more players’ enthusiasm for this game, now miHoYo has released the latest Genshin Impact code.

Keep in mind, Gaess, this redeem code is outside of the Genshin Impact monthly redeem code. So this redeem code can be claimed by players in any region. But this Genshin Impact code does not apply to PS4 players.

Genshin Impact Redeem Code

Players who have not claimed any of the redeem codes last October, must verify that they have claimed all of the previous Genshin Impact codes. After that, players can go to the official miHoYo page to exchange this redeem code: GenshinZHB30. This code should not be upper or lower case and should work on mobile and pc players across the region. Here’s how to claim the redeem code at Genshin Impact:

ALSO READ: How to Get FREE Primogems in Genshin Impact

Visit the official Genshin Impact website below: miHoYo
Login using your Genshin Impact account.
Click the ‘Login’ button.
Select ‘Asian’ Server.
Enter your character’s nickname.
Enter the Genshin Impact redeem code above: GenshinZHB30
Click the redeem button.
Finished.

Once done and confirmed, players just need to turn off their Genshin Impact game and look into Paimon’s Inbox. Later players will get 160 Primogems for free.

ALSO READ: How to Get 5-Star Characters and Weapons in Genshin Impact

That’s the Genshin Impact redeem code. Genshin Impact will get a version 1.1 update in early November. This Genshin Impact 1.1 update will be available to all players on all platforms. Later there will be a lot of new content such as missions, boss battles and playable characters like Childe.

ALSO READ: How to Get Klee Character in Genshin Impact

Hopefully it’s useful, Gaess.
Don’t forget to share with friends on other MedSos.
Thank you.

About the author: @ransltn